Société Générale


SG's earnings recovery gains legs as the execution of the strategic plan unfolds

15/04/24 -"We now factor a stronger recovery into our 2024 (+16%) and 2025 (+15%) EPS projections as we see a higher prospect of recovery for SG. Our 2024 upgrade comes on the back of higher revenue (+2%), ..."

Pages
67
Language
English
Published on
15/04/24
You may also be interested by these reports :
29/04/24
The group posted a strong set of results, driven by better-than-expected activity levels and margins. This led the management to upgrade its guidance ...

29/04/24
We have updated our FY2024 forecasts following the release of the Q1 24 figures and the ensuing profit warning for the Q2 24 and FY2024 due to the ...

26/04/24
The management has maintained its short and mid-term guidance. However, the stronger-than-expected first quarter performance and the likely ...

25/04/24
BNP published better results than expected, thanks to a better outcome in CPBS, a strong cost discipline with notable opex reductions in CIB, the end ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO